Daito Pharmaceutical Co Ltd banner

Daito Pharmaceutical Co Ltd
TSE:4577

Watchlist Manager
Daito Pharmaceutical Co Ltd Logo
Daito Pharmaceutical Co Ltd
TSE:4577
Watchlist
Price: 1 314 JPY -0.68% Market Closed
Market Cap: ¥37.9B

Intrinsic Value

The intrinsic value for Daito Pharmaceutical Co Ltd (4577) under the Base Case is 1 158.52 JPY. Compared with the current market price of 1 314 JPY, the stock appears Overvalued by 12% .

Intrinsic value calculated using DCF
¥1 158.52

Do our valuations actually work? See backtest results .

Intrinsic Value
¥1 158.52
Overvaluation 12%
Intrinsic Value
Price ¥1 314
Monitor Daito Pharmaceutical Co Ltd
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value ¥926.82
Get notified when the price drops into your buy zone
Current Price ¥1 314
Intrinsic Value ¥1 158.52
Margin of Safety 20% ¥926.82
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Ask AI Assistant
What other research platforms think about Daito Pharmaceutical Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Daito Pharmaceutical Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Daito Pharmaceutical Co Ltd.

Explain Valuation
Alternatives to Daito Pharmaceutical Co Ltd

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one Daito Pharmaceutical Co Ltd stock?

The intrinsic value for Daito Pharmaceutical Co Ltd (4577) under the Base Case is 1 158.52 JPY.

Is Daito Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared with the current market price of 1 314 JPY, the stock appears Overvalued by 12% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett